What was claimed

Russian vaccine cures cancer. Skin cancer patient already improving with new immune cells fighting the tumor; it's free

Our verdict

Inaccurate

Reliable sources say there is no evidence of a cancer cure and that the vaccine is still awaiting approval or in early-stage development. Claims of 100% efficacy are described as exaggerated and not backed by clinical evidence. One source says patients would receive it free of charge in Russia if adopted, but this is tied to future state coverage, not confirmed public availability now. Other sources say there is no evidence it has been released for general use.

2 of 3 AI systems agree20 sources citedChecked Aug 1, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

A Russian vaccine cures cancer.

Incorrect94%
All 3 AIs agree

The vaccine is free.

Misleading81%
All 3 AIs agree

A skin cancer patient is already improving with new immune cells fighting the tumor.

Can’t verify59%
All 3 AIs agree

Detailed Analysis

The response makes strong claims that are not supported by reliable evidence. Current reporting says Russia’s cancer-vaccine announcements are still experimental or awaiting approval, and there is no credible proof of a general cancer cure or public rollout. The specific “skin cancer patient already improving” claim is also not established by the sources provided.

Why this verdict

  • The response makes strong claims that are not supported by reliable evidence.
  • Current reporting says Russia’s cancer-vaccine announcements are still experimental or awaiting approval, and there is no credible proof of a general cancer cure or public rollout.
  • The specific “skin cancer patient already improving” claim is also not established by the sources provided.

Claims checked

Russian vaccine cures cancer.

Incorrect96%
Reliable sources say there is no evidence of a cancer cure and that the vaccine is still awaiting approval or in early-stage development. Claims of 100% efficacy are described as exaggerated and not backed by clinical evidence.

This claim may mislead readers without added context.

It's free.

Misleading89%
One source says patients would receive it free of charge in Russia if adopted, but this is tied to future state coverage, not confirmed public availability now. Other sources say there is no evidence it has been released for general use.

This claim may mislead readers without added context.

Skin cancer patient already improving with new immune cells fighting the tumor.

Can’t verify76%
The provided sources mention a first melanoma patient and early results for a personalized vaccine, but they do not verify this exact patient outcome or the wording about immune cells fighting the tumor. The claim is too specific to confirm from the available evidence.

What other AI think

The claim makes multiple false and misleading statements. The vaccine is not a "cure" for cancer—it's experimental and still in early clinical trials. The claim about a skin cancer patient "already improving" is unverifiable and potentially misleading. While some vaccines may eventually be free in Russia, this is not universally established.

Why this verdict

  • The claim makes multiple false and misleading statements.
  • The vaccine is not a "cure" for cancer—it's experimental and still in early clinical trials.
  • The claim about a skin cancer patient "already improving" is unverifiable and potentially misleading.
  • While some vaccines may eventually be free in Russia, this is not universally established.

Claims checked

Russian vaccine cures cancer

Incorrect95%
No confirmed cure has been established yet. The vaccine is still experimental and requires extensive clinical testing before it can be considered a reliable cancer treatment. Labelling Enteromix a 'cure for cancer' is not backed by evidence.

This claim may mislead readers without added context.

It's free

Misleading75%
Russia's Ministry of Health has planned to include cancer vaccines in the country's compulsory medical insurance program in 2026, but the vaccine is not widely available for patients and is still undergoing research and clinical trials. Availability and cost structure remain uncertain for most patients globally.

This claim may mislead readers without added context.

Skin cancer patient already improving with new immune cells fighting the tumor

Can’t verify40%
While versions are being developed for specific forms of melanoma, a type of skin cancer, and initial Phase I trials began in June 2025 with 48 colorectal cancer patients with results showing tumor reduction of 60–80% in some cases, there is no specific evidence of an individual skin cancer patient already improving. This claim cannot be verified from available sources.
The headline claim that a Russian vaccine "cures cancer" is not supported by independent, peer-reviewed clinical evidence. Other elements (a specific skin‑cancer patient improving, and the vaccine being "free") are either unverified or contradicted by available reporting and official statements.

Why this verdict

  • The headline claim that a Russian vaccine "cures cancer" is not supported by independent, peer-reviewed clinical evidence.
  • Other elements (a specific skin‑cancer patient improving, and the vaccine being "free") are either unverified or contradicted by available reporting and official statements.

Claims checked

A Russian vaccine cures cancer.

Incorrect90%
Independent fact checks and medical reporting show Russian announcements describe experimental or preclinical/early clinical work, not a proven universal cure; there is no credible evidence of a widely validated cancer cure from a Russian vaccine.

This claim may mislead readers without added context.

The vaccine is free.

Misleading80%
Russian officials have at times said some treatments might be provided to patients, but reporting cites cost estimates for personalized therapies and no evidence that any Russian cancer vaccine is broadly available free worldwide.

This claim may mislead readers without added context.

A skin cancer patient is already improving with new immune cells fighting the tumor.

Can’t verify60%
Anecdotal reports circulate, but I cannot verify a specific, documented patient case with independently reviewed clinical data or published medical records.

Share this result